Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-10-26

FDA Approved: ADEFOVIR DIPIVOXIL — Supplemental Application (Sigmapharm Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for Adefovir Dipivoxil from Sigmapharm Laboratories, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adefovir Dipivoxil (Adefovir dipivoxil)

Snippet

SUPPL AP for ADEFOVIR DIPIVOXIL (ADEFOVIR DIPIVOXIL)